An interventional study of Exercise Intervention in Aging, Sarcopenia and Disability Physical, sponsored by Louisiana State University and A&M College. Completed at 2 sites in United States. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-19.
Sponsored by Louisiana State University and A&M College · Not applicable, Interventional, and Prevention
What are the effects of resistance exercise (RE) alone or RE plus low intensity physical activity (LPA) breaks in sedentary time (ST) on skeletal muscle health in older adults?
What are the effects of resistance exercise (RE) alone or RE plus low intensity physical activity (LPA) breaks in sedentary time (ST) on skeletal cardiometabolic health in older adults?
Although awareness of the detrimental impact that sedentary behavior has on skeletal muscle and cardiometabolic health has increased over the last 20 years, more than 60% of older adults remain sedentary for greater than 8 hours per day. Moreover, 80% to 90% of adults 60 years of age or older do not meet the current public health guidelines for aerobic exercise (AE) or resistance exercise (RE) based physical activity (PA). Collectively, these adverse health behaviors contribute to the development of multiple chronic medical conditions commonly afflicting older adults, including type 2 diabetes, cardiovascular disease, sarco/dynapenia, frailty, and premature mortality. Emerging evidence suggests that breaking up sedentary time with light intensity PA (LPA) improves muscle and cardiometabolic health. Recent data also suggest that RE combined with moderate intensity AE effectively improves muscle and cardiometabolic health in older adults. However, the impact that RE combined with LPA breaks in sedentary time has on muscle and cardiometabolic health in older adults remains unknown. The overall objective of this pilot study is to determine the effect of 16 weeks of RE alone or RE combined with LPA breaks in sedentary time on muscle and cardiometabolic health.
1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.
This study's enrollment of 24 is below the median of 60 across 775 interventional studies indexed under Sarcopenia.
Browse Sarcopenia studies →Louisiana State University and A&M College is the lead sponsor of 13 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Stable medical therapy for allowable medications for 30 days defined as:
Exclusion Criteria:
Physically Active:
a. > 100 min/wk of moderate OR > 50 min/wk vigorous intensity PA
Use of medications known to influence study outcomes, such as:
c. Anticoagulants
Absolute Contraindication to Exercise as Defined by the American College of Sports Medicine,16 including:
Exercise Intervention: Participants will be asked to complete supervised resistance exercise 2 days per week.
Behavioral: Exercise Intervention
Exercise Intervention: Participants will be asked to complete supervised resistance exercise 2 days per week and regular unsupervised low intensity physical activity breaks in sedentary time 5 days per week \[6x10 min breaks/d at 2 metabolic equivalents (METS) or \~30-40% peak oxygen consumption (VO2 peak), \~500 kcal/wk above resting metabolism\].
Behavioral: Exercise Intervention
Exercise Intervention: Participants will be asked to complete supervised RE 2 days per week and supervised calorically matched moderate intensity physical activity 3 days per week (50 min/session at 4 METS (\~60-75% VO2 peak), \~500 kcal/week above resting metabolism).
Behavioral: Exercise Intervention
The use of exercise to improve muscle and cardiometabolic health in older adults.
Skeletal Muscle Strength
The investigators will determine the change from baseline in skeletal muscle strength. These measurements will be performed at baseline and following 16 weeks of exercise training using isokinetic dynamometry and 1 repetition maximum testing.
Time frame: Measured at week 0 (baseline) and week 16
Skeletal Muscle Mass
The investigators will determine the change from baseline in skeletal muscle mass. These measurements will be performed at baseline and following 16 weeks of exercise training using Dual X-Ray Absorptiometry.
Time frame: Measured at week 0 (baseline) and week 16
Mitochondrial Function
The investigators will determine the change from baseline in mitochondrial function. These measurements will be performed at baseline and following 16 weeks of exercise training.
Time frame: Measured at week 0 (baseline) and week 16
| Milestone | Resistance Exercise | RE Plus Low Intensity Physical Activity | RE Plus Moderate Intensity Exercise |
|---|---|---|---|
| Started | 7 | 8 | 8 |
| Completed | 6 | 7 | 8 |
| Not completed | 1 | 1 | 0 |
| Withdrew: Withdrawal by subject | 1 | 0 | 0 |
| Withdrew: Covid-19 shutdown | 0 | 1 | 0 |
The investigators will determine the change from baseline in skeletal muscle strength. These measurements will be performed at baseline and following 16 weeks of exercise training using isokinetic dynamometry and 1 repetition maximum testing.
| Change in Lbs | Resistance Exercise | RE Plus Moderate Intensity Exercise | RE Plus Low Intensity Physical Activity |
|---|---|---|---|
| Skeletal Muscle Strength | 93.9 ± 17.9 | 50.0 ± 15.2 | 78.6 ± 15.2 |
The investigators will determine the change from baseline in skeletal muscle mass. These measurements will be performed at baseline and following 16 weeks of exercise training using Dual X-Ray Absorptiometry.
| Change Appendicular Lean Mass (kg/m^2) | Resistance Exercise | RE Plus Moderate Intensity Exercise | RE Plus Low Intensity Physical Activity |
|---|---|---|---|
| Skeletal Muscle Mass | 0.22 ± 0.11 | 0.17 ± 0.10 | 0.27 ± 0.10 |
The investigators will determine the change from baseline in mitochondrial function. These measurements will be performed at baseline and following 16 weeks of exercise training.
| pmols/sec/mg wet weight | Resistance Exercise | RE Plus Low Intensity Physical Activity | RE Plus Moderate IntensityExercise |
|---|---|---|---|
| Mitochondrial Function | 27.2 ± 5.9 | 17.0 ± 5.4 | 5.9 ± 8.3 |
Collected over During study period, up to 16 weeks. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Resistance Exercise | 0/7 (0%) | 0/7 (0%) | 0/7 (0%) |
| RE Plus Moderate Intensity Exercise | 0/8 (0%) | 0/8 (0%) | 0/8 (0%) |
| RE Plus Low Intensity Physical Activity | 0/8 (0%) | 0/8 (0%) | 2/8 (25%) |
| Event | Resistance Exercise | RE Plus Moderate Intensity Exercise | RE Plus Low Intensity Physical Activity |
|---|---|---|---|
| FallInvestigations | 0/7 | 0/8 | 1/8 |
| VasovagalCardiac disorders | 0/7 | 0/8 | 1/8 |
One participant in the resistance training group withdrew from the study due to time conflict, and one participant in the RE plus Low Intensity Physical Activity was lost to follow-up due to shutdown of campus during the beginning of the covid 19 pandemic.
| Age, Continuous(years) | Resistance Exercise | RE Plus Low Intensity Physical Activity | RE Plus Moderate IntensityExercise | Total |
|---|---|---|---|---|
| Mean | 70.3 ± 2.9 | 70.4 ± 3.9 | 69.5 ± 5.0 | 70.0 ± 3.9 |
| Sex: Female, Male(Participants) | Resistance Exercise | RE Plus Low Intensity Physical Activity | RE Plus Moderate IntensityExercise | Total |
|---|---|---|---|---|
| Female | 5 | 6 | 5 | 16 |
| Male | 2 | 2 | 3 | 7 |
| Race (NIH/OMB)(Participants) | Resistance Exercise | RE Plus Low Intensity Physical Activity | RE Plus Moderate IntensityExercise | Total |
|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 |
| Black or African American | 2 | 1 | 1 | 4 |
| White | 5 | 7 | 7 | 19 |
| More than one race | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 |
| Region of Enrollment(participants) | Resistance Exercise | RE Plus Low Intensity Physical Activity | RE Plus Moderate IntensityExercise | Total |
|---|---|---|---|---|
| United States | 7 | 8 | 8 | 23 |
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Louisiana State University and A&M College